Evaluating threshold for donor fraction cell‐free <scp>DNA</scp> using clinically available assay for rejection in pediatric and adult heart transplantation

The study suggests that pediatric patients with rejection show higher levels of circulating df-cfDNA compared to adults and supports the specific cut points for clinical use in pediatric and adult patients with overall acceptable performance.